Sabra Health Care REIT/ US78573L1061 /
2024-09-19 9:59:57 PM | Chg. -0.64 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
18.36USD | -3.37% | 122,075 Turnover: 2.25 mill. |
18.36Bid Size: 100 | 18.38Ask Size: 500 | 4.3 bill.USD | 6.54% | 306.00 |
Assets
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | - | - | - | - | - | ||||||
Intangible Assets | 167.1190 | 131.0970 | 101.5090 | 82.7960 | 54.0630 | ||||||
Long-Term Investments | - | 340.1200 | 319.4600 | 288.7610 | 96.6800 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 283.2770 | 280.8830 | 257.8170 | 263.4850 | 537.1940 | ||||||
Cash and Cash Equivalents | 518.6320 | 50.2300 | 39.0970 | 59.0760 | 111.9960 | ||||||
Current Assets | - | - | - | - | - | ||||||
Total Assets | 7,032.2770 | 6,665.3030 | 6,069.2990 | 5,985.6030 | 5,966.7070 |
Liabilities
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 102.5230 | 94.8270 | 108.7920 | 146.2760 | 142.9890 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 3,595.0280 | 3,410.5560 | 2,580.8390 | 2,576.3750 | 2,587.1770 | ||||||
Share Capital | 1.7830 | 1.7830 | 2.0520 | 2.1060 | 2.3040 | ||||||
Total Equity | 3,437.2490 | 3,254.7470 | 3,488.4600 | 3,409.2280 | 3,379.5300 | ||||||
Minority Interests | 4.4420 | 4.3330 | 0.0000 | 0.0000 | - | ||||||
Total liabilities equity | 7,032.2770 | 6,665.3030 | 6,069.2990 | 5,985.6030 | 5,966.7070 |
Income Statement
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 405.6470 | 623.4090 | 661.7360 | 598.5690 | 569.5450 | ||||||
Depreciation (total) | 113.8820 | 191.3790 | 181.5490 | 176.7370 | 178.9910 | ||||||
Operating Result | - | - | - | - | - | ||||||
Interest Income | -88.4400 | -147.1060 | -126.6100 | -100.4000 | -98.6000 | ||||||
Income Before Taxes | 159.0160 | 287.5570 | 79.2160 | 155.7260 | 80.6700 | ||||||
Income Taxes | .6510 | 3.0110 | 3.4020 | .7100 | 1.8450 | ||||||
Minority Interests Profit | .0180 | -.0330 | -.0220 | 0.0000 | - | ||||||
Net Income | 148.1410 | 269.3140 | 68.9960 | 138.4170 | -113.2560 |
Per Share
Cash Flow
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 133.4860 | 358.5430 | 372.4750 | 354.8520 | 356.3900 | ||||||
Cash Flow from Investing Activities | -240.0720 | -258.4940 | 262.8440 | -136.4510 | -336.1960 | ||||||
Cash Flow from Financing | 598.8170 | -627.3010 | -646.1800 | -202.1090 | 30.1400 | ||||||
Decrease / Increase in Cash | 492.2310 | -527.2520 | -10.8610 | 16.2920 | 50.3340 | ||||||
Employees | 61 | 31 | 34 | - | - |